After spending eight weeks on campus this summer conducting funded neuroscience research as part of Conn’s Summer Science Institute, Anjum Shaikh ’22 had an opportunity to share her work with the ...

WALTHAM, Mass.--(BUSINESS WIRE)--Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced a scientific poster presentation highlighting ATACs ...

STATEN ISLAND, N.Y., May 4, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics ...

Every other year in February, the world of oceanography descends upon a conference center somewhere in the world to talk science, showcase innovations and network. It is a chance to see and be seen ...

Presenting your poster at a Labroots Virtual Event can provide valuable research insights and feedback from peers in the comfort of your home or office. Every Labroots virtual event features a virtual ...

NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by ...

MORRISVILLE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with ...

Walk into any academic conference, and you will find a flock of bright minds, pacing beside large printed panels, rehearsing with their breath in tremor – the feared “two-minuter”. The taut eyes of ...

American Society of Gene and Cell Therapy 29th Annual Meeting (ASGCT) TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference 3rd International Conference on Ureagenesis Defects and Allied ...

Front Cover -- Designing Science Presentations -- Designing Science Presentations -- Copyright -- Contents -- About the author -- Acknowledgments -- 1 -- Using design ...

DNA pol IIIC inhibitors demonstrate a class effect of potentially clinically-relevant gut microbiome preservation while demonstrating systemic antibacterial activity Acurx's DNA pol IIIC inhibitor ...